Attached files

file filename
EX-31.2 - CERTIFICATION OF CFO REQUIRED BY RULE 13A-15(E) OR RULE 15D-15(E) - HANSEN MEDICAL INCdex312.htm
EX-10.48 - AMENDED AND RESTATED RETENTION AGREEMENT - ROBERT MITTENDORFF - HANSEN MEDICAL INCdex1048.htm
EX-10.59 - OFFER LETTER - KENNETH T. HUSTED - HANSEN MEDICAL INCdex1059.htm
EX-21.1 - LIST OF SUBSIDIARIES OF THE REGISTRANT - HANSEN MEDICAL INCdex211.htm
EX-10.56 - EMPLOYMENT AGREEMENT - ROLAND PEPLINSKI - HANSEN MEDICAL INCdex1056.htm
EX-23.1 - CONSENT OF DELOITTE & TOUCHE LLP - HANSEN MEDICAL INCdex231.htm
EX-10.55 - OFFER LETTER - RITA V. JACOB - HANSEN MEDICAL INCdex1055.htm
EX-23.2 - CONSENT OF PRICEWATERHOUSECOOPERS LLP - HANSEN MEDICAL INCdex232.htm
EX-10.54 - OFFER LETTER- JEAN CHANG - HANSEN MEDICAL INCdex1054.htm
EX-32.2 - CERTIFICATION OF CFO REQUIRED BY RULE 13A-14(B) OR RULE 15D-14(B) - HANSEN MEDICAL INCdex322.htm
EX-10.6 - FORM OF OFFERING DOCUMENT UNDER 2006 EMPLOYEE STOCK PURCHASE PLAN - HANSEN MEDICAL INCdex106.htm
EX-32.1 - CERTIFICATION OF CEO REQUIRED BY RULE 13A-14(B) OR RULE 15D-14(B) - HANSEN MEDICAL INCdex321.htm
EX-10.58 - OFFER LETTER - ARTHUR S. HSIEH - HANSEN MEDICAL INCdex1058.htm
EX-10.57 - OFFER LETTER - FRANK M. SCHEMBRI, JR. - HANSEN MEDICAL INCdex1057.htm
EX-10.52 - WAIVER BY BRUCE J BARCLAY - HANSEN MEDICAL INCdex1052.htm
EX-10.50 - WAIVER BY FREDERIC H. MOLL, M.D. - HANSEN MEDICAL INCdex1050.htm
EX-10.49 - FORMS OF RESTRICTED STOCK UNIT AGREEMENTS UNDER THE 2006 EQUITY INCENTIVE PLAN - HANSEN MEDICAL INCdex1049.htm
EX-10.51 - WAIVER BY BRUCE J BARCLAY - HANSEN MEDICAL INCdex1051.htm
EX-10.60 - OFFER LETTER - DANIEL WALLACE - HANSEN MEDICAL INCdex1060.htm
EX-10.53 - FORM OF RETENTION AGREEMENT FOR EXECUTIVE OFFICERS - HANSEN MEDICAL INCdex1053.htm
10-K - FORM 10-K - HANSEN MEDICAL INCd10k.htm

Exhibit 31.1

CERTIFICATION

I, Bruce J Barclay, certify that:

1. I have reviewed this Annual Report on Form 10-K of Hansen Medical, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

March 15, 2011

/s/ Bruce J Barclay

President and Chief Executive Officer

(Principal Executive Officer)